Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases

Cell Death and Differentiation

Volumn 7, Issue 5, 2000, Pages 447-460

  Gianni M ^a   Ponzanelli, I ^a   Mologni, L ^a   Reichert, U ^b   Rambaldi, A ^c   Terao, M ^a   Garattini, E ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Galderma R and D   (France)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

APL; ATRA; Caspase; Retinoids

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; ALITRETINOIN; CASPASE; CASPASE INHIBITOR; CYTOCHROME C; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; RETINOIC ACID; RETINOID; RETINOID X RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVATION; GRANULOCYTE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034114690     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400673     Document Type: Article

References (48)

1. Gudas LJ, Sporn MB and Roberts AB (1994)Cellular Biology and Biochemistry of Retinoids. In: The Retinoids: Biology, Biochemistry and Medicine. Sporn MB, Roberts AB and Goodman DS (eds). New York: Raven Press, pp. 443-520
2. Warrell Jr RP, Frankel SR, Miller Jr WJ, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS and Dmitrovsky E (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 324: 1385-1393
3. Kantarjian HM, Keating MJ, Walters RS, Estey EH, McCredie KB, Smith TL, Dalton Jr WT, Cork A, Trujillo JM and Freireich EJ (1986) Acute promyelocytic leukemia. M.D. Anderson hospital experience. Am. J. Med. 80: 789-797
4. Elliott S, Taylor K, White S, Rodwell R, Marlton P, Meagher D, Wiley J, Taylor D, Wright S and Timms P (1992) Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood 79: 1916-1919
5. Bruel A, Karsenty E, Schmid M, McDonnell TJ and Lanotte M (1997) Altered sensitivity to retinoid-induced apoptosis associated with changes in the subcellular distribution of Bcl-2. Exp. Cell. Res. 233: 281-287
6. Taimi M and Breitman TR (1997) Growth, differentiation, and death of retinoic acid-treated human acute promyelocytic leukemia NB4 cells. Exp. Cell. Res. 230: 69-75
7. Chen JY, Clifford J, Zusi C, Starrett J, Tortolani D, Ostrowski J, Reczek PR, Chambon P and Gronemeyer H (1996) Two distinct actions of retinoid-receptor ligands. Nature 382: 819-822
8. Bruel A, Benoit G, De Nay D, Brown S and Lanotte M (1995) Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression. Leukemia 9: 1173-1184
9. Gallagher R, Collins S, Trujillo J, McCredie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Ruscetti F and Gallor R (1979) Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54: 713-733
10. Gianni' M, Li Calzi M, Terao M, Caccia S, Guiso G, Barbui T, Rambaldi A and Garrattini E (1996) AM580, a stable benzoic derivative of all-trans retinoic acid, is more active than the parent compound in activating the acute promyelocytic luekemia-specific aberrant form of RAR and in inducing granulocytic maturation of APL cells. Blood 87: 1520-1531
11. Nagy L, Thomazy VA, Shipley GL, Fesus L, Lamph W, Heyman RA, Chandraratna RA and Davies PJ (1995) Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15: 3540-3551
12. Melnick A and Licht JD (1999) Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167-3215
13. Wolf BB and Green DR (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J. Biol. Chem. 274: 20049-20052
14. Porter AG and Janicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6: 99-104
15. Nunez G, Benedict MA, Hu Y and Inohara N (1998) Caspases: the proteases of the apoptotic pathway. Oncogene 17: 3237-3245
16. Brancolini C and Schneider C (1997) Cut and die: proteolytic cascades regulating apoptosis. Adv. Clin. Path. 1: 177-189
17. Wilson MR (1998) Apoptosis: unmasking the executioner. Cell Death Differ. 5: 646-652
18. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K,Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit V (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827
19. Muzio M, Salvesen GS and Dixit VM (1997) FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J. Biol. Chem. 272: 2952-2956
20. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P and Korsmeyer SJ (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274: 1156-1163
21. Nervi C, Ferrara FF, Fanelli M, Rippo MR, Tomassini B, Ferrucci PF, Ruthardt M, Gelmetti V, Gambacorti-Passerini C, Diverio D, Grignani F, Pelicci PG and Testi R (1998) Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein. Blood 92: 2244-2251
22. Luca Mologni, Isabella Ponzanelli, Filippo Bresciani, Gabriele Sardiello, Daniele Bergamaschi, Maurizio Gianni', Uwe Reichert, Alessandro Rambaldi, Mineko Terao and Enrico Garattini (1999) The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphtalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases. Blood 93: 1045-1061
23. Dermime S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG and Gambacorti-Passerini C (1993) Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein. Blood 82: 1573-1577
24. Mangelsorf DJ, Ong ES, Dyck JA and Evans RM (1990) Nuclear recepotor that identifies a novel retinoic acid response pathway. Nature 345: 224-229
25. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM and Thaller C (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68: 397-394
26. Gianni' M, Terao M, Zanotta S, Barbui T, Rambaldi A and Garattini E (1994) Retinoic acid and granulocyte-colony stimulating factor sinergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Blood 83: 1909-1921
27. Strickland S, Breitman TR, Frickel F, Nurrenbach A, Hadicke E and Sporn MB (1983) Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. Cancer Res. 43: 5268-5272
28. Gianni M, Zanotta S, Terao M, Garattini S and Garattini E (1993) Effects of synthetic retinoids and retinoic acid isomers on the expression of alkaline phosphatase in F9 teratocarcinoma cells. Biochem. Biophys. Res. Commun. 196: 252-259
29. Sorensen S, Solvsten H, Politi Y and Kragballe K (1997) Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors. Skin Pharmacol 10: 144-152
30. Lala DS, Mukherjee R, Schulman IG, Koch SS, Dardashti LJ, Nadzan AM, Croston GE, Evans RM and Heyman RA (1996) Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature 383: 450-453
31. Schumann RR, Belka C, Reuter D, Lamping N, Kirschning CJ, Weber JR and Pfeil D (1998) Lipopolysaccharide activates caspase-1 (interleukin-1 -converting enzyme) in cultured monocytic and endothelial cells. Blood 91: 577-584
32. Rano TA, Timkey T, Peterson EP, Rotonda J, Nicolson DW, Becker JW, Chapman KT and Thornberry NA (1997) A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE). Chem. Biol. 4: 149-155
33. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT and Nicholson D (1997) A combinatorial approach defines specificities of members of the caspase family and granzyrne B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272: 17907-17911
34. Takahashi A, Goldschmidt-Clermont PJ, Alnemri ES, Fernandes-Alnemri T, Yoshizawa-Kumagaya K, Nakajima K, Sasada M, Poirier GG and Earnshaw WC (1997) Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide. Exp. Cell Res. 231: 123-131
35. Rosen A and Casciola-Rosen L (1997) Macromolecular substrates for the ICE-like proteases during apoptosis. J. Cell Biochem. 64: 50-54
36. Green DR and Reed JC (1998) Mitochondria and apoptosis. Science 281: 1309-1312
37. Qin H, Srinivasula SM, Wu G, Fernandes-Alnemri T, Alnerrbri ES and Shi Y (1999) Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399: 549-557
38. Gross A, McDonnell JM and Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911
39. Rogaia D, Grignani F, Grignani F, Nicoletti I and Pelicci PG (1995) The acute promyelocytic leukemia-specific PML/RAR alpha fusion protein reduces the frequency of commitment to apoptosis upon growth factor deprivation of GM-CSF-dependent myeloid cells. Leukemia 9: 1467-1472
40. van der Burg B, Slager-Davidov R, van der Leede BM, de Laat SW and van der Saag PT (1995) Differential regulation of AP1 activity by retinoic acid in hormone-dependent and -independent breast cancer cells. Mol. Cell Endocrinol. 112: 143-152
41. Casini T and Pelicci PG (1999) A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest. Oncogene 18: 3235-3243
42. Watson RW, Rotstein OD, Parodo J, Bitar R, Hackam D and Marshall JC (1997) Granulocytic differentiation of HL-60 cells results in spontaneous apoptosis mediated by increased caspase expression. FEBS Lett. 412: 603-609
43. Tepper AD, de Vries E, van Blitterswijk WJ and Borst J (1999) Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95-and DNA damage-induced apoptosis. J. Clin. Invest. 103: 971-978
44. Li H, Zhu H, Xu CJ and Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501
45. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R and Naoe T (1996) Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res. 56: 2945-2948
46. Agarwal C, Chandraratna RA, Johnson AT, Rorke EA and Eckert RL (1996) AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells. J. Biol. Chem. 271: 12209-12212
47. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F and Berger R (1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77: 1080-1086
48. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254